Literature DB >> 15353716

Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator.

F Vanhavere1, D Huyskens, L Struelens.   

Abstract

More and more attention is being given in radiotherapy to the doses received by organs other than the target organ. With increasing survival time of the patients, the risks of secondary malignancies need to be lowered as much as possible. So total body doses are worth estimating in radiotherapy. The introduction of intensity modulated radiotherapy (IMRT) needs an increase in the number of monitor units given to the patient. So there is a risk of increasing the peripheral doses using this technique. Another aspect, mostly neglected, is the neutron peripheral dose that occurs when LINAC energies above 8 MeV are used. We did measurements for both gammas and neutrons with an 18 MV Varian accelerator for a prostate cancer treatment. The measurements were done both free-in-air, at different depths in a plexi-phantom, and using a Rando-Alderson phantom. Effective doses for the total body outside the treatment area are estimated using these measurements.

Entities:  

Mesh:

Year:  2004        PMID: 15353716     DOI: 10.1093/rpd/nch135

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  11 in total

Review 1.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

2.  Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.

Authors:  Bryan Bednarz; Cindy Hancox; X George Xu
Journal:  Phys Med Biol       Date:  2009-08-11       Impact factor: 3.609

3.  Consideration of the radiation dose delivered away from the treatment field to patients in radiotherapy.

Authors:  Michael L Taylor; Tomas Kron
Journal:  J Med Phys       Date:  2011-04

4.  Neutron dose measurements of Varian and Elekta linacs by TLD600 and TLD700 dosimeters and comparison with MCNP calculations.

Authors:  Hassan Ali Nedaie; Hoda Darestani; Nooshin Banaee; Negin Shagholi; Kheirollah Mohammadi; Arjang Shahvar; Esmaeel Bayat
Journal:  J Med Phys       Date:  2014-01

5.  Effects of field parameters on IMRT plan quality for gynecological cancer: a case study.

Authors:  Albert Y C Fung; Charles A Enke; Komanduri M Ayyangar; Robert B Thompson; Weining Zhen; Natarajan V Raman; David Djajaputra; Sicong Li; Ramasamy M Nehru; Sushakumari Pillai; Paul Sourivong; Mary Headley; Ann L Yager
Journal:  J Appl Clin Med Phys       Date:  2005-08-12       Impact factor: 2.102

6.  Radiation-Induced Second Cancer Risk from External Beam Photon Radiotherapy for Head and Neck Cancer: Impact on in-Field and Out-of-Field Organs

Authors:  Vasanthan Sakthivel; Ganesh Kadirampatti Mani; Sunil Mani; Raghavendiran Boopathy
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

7.  Breakthrough whole body energy-specific and tissue-specific photoneutron dosimetry by novel miniature neutron dosimeter/spectrometer.

Authors:  Mehdi Sohrabi; Morteza Ebrahimzadeh Torkamani
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

Review 8.  Mathematical formulation of energy minimization - based inverse optimization.

Authors:  Ivaylo B Mihaylov
Journal:  Front Oncol       Date:  2014-07-18       Impact factor: 6.244

9.  Beta burns following radionuclide synovectomy.

Authors:  Marek Marcin Chojnowski; Maria Teresa Płazińska; Marek Sławomir Chojnowski; Leszek Królicki
Journal:  Reumatologia       Date:  2018-06-30

10.  The influence of shielding reinforcement in a vault with limited dimensions on the neutron dose equivalent in vicinity of medical electron linear accelerator.

Authors:  Ana Ivkovic; Dario Faj; Mladen Kasabasic; Marina Poje Sovilj; Ivana Krpan; Marina Grabar Branilovic; Hrvoje Brkic
Journal:  Radiol Oncol       Date:  2020-05-02       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.